Australia markets closed

Repro Med Systems, Inc. (KRMD)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
2.3500+0.1200 (+5.38%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close2.2300
Open2.2300
Bid2.2800 x 1000
Ask2.3600 x 1000
Day's range2.2300 - 2.3500
52-week range1.9000 - 4.8300
Volume7,834
Avg. volume41,252
Market cap105.441M
Beta (5Y monthly)0.38
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    KORU Medical Systems Announces 2022 First Quarter Financial Results

    CHESTER, N.Y., May 04, 2022--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today reported financial results for the first quarter ended March 31, 2022.

  • Business Wire

    KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge®

    CHESTER, N.Y., May 02, 2022--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty infusion solutions that improve quality of life for patients, today announced 510k clearance for use of the KORU Medical FreedomEdge® infusion system to deliver pegcetacoplan 20 mL solution, branded as EMPAVELI® or Aspaveli® and c

  • Business Wire

    KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022

    CHESTER, N.Y., April 20, 2022--Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development of innovative and easy-to-use home infusion solutions, today announced that the Company will report first quarter 2022 financial results on Wednesday, May 4, 2022. KORU Medical’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corp